Thirty-four episodes of pneumococcal bacteremia were identified in 15 patients over 5 years in 10 hospitals in Franklin County, Ohio. Twelve patients each had 2 episodes of pneumococcal bacteremia, 2 had 3, and 1 had 4. All patients had predisposing conditions, with lymphoma, multiple myeloma, and chronic obstructive pulmonary disease being the most frequent. The mean interval between the first and second episode was 268 days. Serotyping and genotyping were performed on 29 isolates. The same serotypic and genotypic patterns were found for sequential isolates from four patients; three of these patients had a recurrence between 22 and 90 days after a previous episode. Seven (24%) of the 29 isolates were serotype 23F; four isolates (14%) were not susceptible to penicillin. All of our patients received appropriate antimicrobial therapy and appeared to be clinically cured of their initial infection. For patients with recurrent pneumococcal disease, alternate preventive measures such as immunization with conjugate pneumococcal vaccine and/or prophylactic antibiotic therapy should be considered.
second and third episode was 101 days. One patient had a Pneumonia was present in 27 (79%) of the 34 bacteremic episodes. In two of these episodes, meningitis was also present. fourth episode 571 days after the third episode. Of the 19 recurrent episodes (i.e., second, third, and fourth episodes), Meningitis without pneumonia occurred in one episode. In six episodes, no obvious primary site was detected. seven occurred between 22 and 90 days after the previous episode. In three of these seven episodes, the isolates matched Underlying medical conditions were present in all patients (table 1): lymphoma (4 patients), multiple myeloma and diabeby both serotyping and PCR pattern. A fourth matching pair of isolates was from a patient with two episodes separated by tes mellitus (2), multiple myeloma (1), chronic obstructive pulmonary disease (3), HIV infection (1), congestive heart failure ú1 year. All the other recurrences that occurred ú90 days later were associated with different serotypes and genotypes.
(1), lung cancer (1), cirrhosis (1), and CSF leak after a craniotomy for treatment of meningioma (1). Seven patients were male, and eight were female. The mean age of the patients was 57 years (range, 24 -75 years), and six Twenty-nine isolates were available for testing. Serotypes identified included 23F (7 isolates), 14 (3), 4 (3), 1 (2), 6A patients were 65 years of age or older. Of the 15 patients, one (6.7%; patient 10) died during a recurrent episode of pneumo- / 9c4a$$ap11
03-09-98 19:20:44 cida UC: CID racial differences were seen in our 15 patients with recurrent pneumococcal bacteremia, although the sample size was small. Little data on recurrent disease exist [6, 7] . RodriguezCreixems et al. [6] reported that of 532 patients with pneumococcal bacteremia, 15 (2.8%) had a second episode within a 10-year period. The presence of multiple myeloma was considered a predictor for recurrent infection. Our patients had similar predisposing conditions, with lymphoma and multiple myeloma being two of the most frequent conditions (table 1) .
The mortality rate in this study was relatively low compared with that in the study by Rodriguez-Creixems et al. [6] . One possible explanation is that while only five patients in our study received the pneumococcal vaccine, no patient had received the vaccine in the Spanish study. Only one patient with AIDS was identified in the current study, while AIDS (occurring in four of 15 patients) was one of the most frequent underlying diseases along with multiple myeloma and solid tumors in the Spanish study.
Paired isolates from 10 (71%) of 14 episodes were discordant by both serotyping and DNA banding patterns and clearly represent a new infection (table 1) . However, the pathogenesis of recurrent pneumococcal bacteremia is less clear in the four episodes with concordant isolate pairs by serotyping and DNA banding pattern. Our patients received appropriate antimicrobial therapy and appeared to be clinically cured of their initial infection; none of the patients had evidence of endocarditis, quate to eradicate colonization. Two of our patients with concordant isolate pairs from sequential infections had meningitis due to serotype 23F; one had a recurrent episode separated by ú1 year from the first episode. Possibly, long-term colonization overrepresented compared with isolates from patients with a single episode of bacteremia who were from Franklin County of the paranasal sinuses was present in this patient. Unfortunately, since this was a retrospective review, we did not have (24% vs. 9.7%, respectively; P Å .03) [3] . All serotypes except serotypes 13 and 37 are included in the polysaccharide vaccine.
culture specimens of the nasopharynx or sinuses to further elucidate the pathogenesis. There were three pairs of sequential isolates with common serotypes, and 10 pairs of isolates with discordant serotypes.
All of our patients had indications for pneumococcal vaccine, although only one-third (five of 15) had been immunized (table An additional pair of isolates with a common serotype was identified in a first and third episode of bacteremia. The isolate 1). Unfortunately, serum samples were not available to measure the antibody response to the vaccine. Clinical trials of a conjufrom the second episode was not saved (table 1) .
There were 25 different banding patterns for the 29 isolates gate pneumococcal vaccine are currently under way, and this vaccine may provide better immunity in patients with suboptiby REP PCR analysis. The banding pattern was the same for each of the four isolate pairs with the same serotypes (figure mal immune systems [8 -10] . In the unusual case of multiple episodes of invasive pneumococcal disease, prophylactic anti-1). The other 10 isolate pairs had different banding patterns.
All patients received appropriate antimicrobial therapy. biotic administration may be of benefit, as seen in the children with sickle-cell disease [11] . There were no differences in duration of therapy between those patients with concordant isolates from recurrent episodes and those with different isolates from recurrent episodes.
